Bridge financing through the issuance of convertible bonds to Vester Finance and European investors for €1.8m
Immediate receipt of the entire financing upon signing
Cash runway extended to November 2025, providing sufficient financial visibility to complete the safeguard process
Structuring of a financing plan with long-term strategic investors underway to support the future development of the Company
Paris and Boston, July 10, 2025 – 7:00 pm CEST – Mauna Kea Technologies (Euronext Growth: ALMKT), inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser endomicroscopy (p/nCLE) platform, today announces that it has secured a bridge financing through the issuance of convertible bonds to European investors, including Vester Finance, a Company’s shareholder and long-term financing partner.
This financing immediately extends Mauna Kea Technologies’ financial visibility through November 2025, beyond the timeframe of the ongoing safeguard procedure. It provides the Company with the flexibility needed to complete its financial restructuring and finalize the presentation of its safeguard plan. Mauna Kea Technologies is also working on structuring a bridge financing intended to ensure business continuity during the observation period.
In parallel, the Company is actively structuring a long-term financing plan with strategic investors and family offices to sustainably support Mauna Kea Technologies’ operational development.
Sacha Loiseau, Ph.D., Chief Executive Officer of Mauna Kea Technologies, stated: “I would like to sincerely thank the investors for their valuable support, as well as Vester Finance, a long-standing partner of the Company, for reiterating its support and confidence. With a deliberately targeted amount, this bridge financing is perfectly suited to our current needs, extending our cash runway for the time required to finalize our recovery plan with all stakeholders, while preserving maximum options for the future.”
